Krilogy Financial’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Krilogy Financial’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-56	Closed	-$1K	–	710
2018 Q3	$1K	Buy	+56	New	+$1.7K	﹤0.01%	797
2018 Q2	–	Sell	-56	Closed	-$4K	–	654
2018 Q1	$4K	Hold	56	–	–	﹤0.01%	637
2017 Q4	$4K	Hold	56	–	–	﹤0.01%	640
2017 Q3	$5K	Hold	56	–	–	﹤0.01%	664
2017 Q2	$4K	Hold	56	–	–	﹤0.01%	622
2017 Q1	$5K	Hold	56	–	–	﹤0.01%	580
2016 Q4	$5K	Hold	56	–	–	﹤0.01%	580
2016 Q3	$8K	Sell	56 -55	-50%	-$5.46K	﹤0.01%	553
2016 Q2	$11K	Buy	+111	New	+$13.8K	﹤0.01%	524

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Krilogy Financial's LUMO Position: Q4 2018 in Review

Krilogy Financial sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2018, closing a stake of 56 shares — an estimated $1K sold.

Krilogy Financial first reported a position in LUMO in Q2 2016 and held it in 9 quarters. The position peaked at $11K in Q2 2016. 87 funds tracked by Wall St. Rank hold LUMO as of Q4 2018.

Krilogy Financial reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Krilogy Financial sold 56 Lumos Pharma, Inc. Common Stock shares in Q4 2018, an estimated $1K.
Krilogy Financial first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2016 and held it in 9 quarters.
Krilogy Financial's Lumos Pharma, Inc. Common Stock position peaked at $11K in Q2 2016.
87 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.